Search Results 1341-1350 of 21996 for Inhibition
Use of immune checkpoint inhibitors (e.g., ipilimumab) within 60 months prior to screening. Use of agents that deplete B or T cells (e.g., rituximab ...
Participant, International Multicenter Immune Checkpoint Inhibitors Consortium in Kidney Transplantation, 2021-present. Medical leader, Kidney Transplant ...
You should not use this medicine if you or your child have used an MAO inhibitor (MAOI), including isocarboxazid, phenelzine, Eldepryl®, Marplan®, Nardil ...
... inhibitors) for their cancer or if they have received prior total body irradiation which included the brain - History of myocardial infarction =< 6 months ...
Inhibition of 11beta-Hydroxysteroid dehydrogenase-1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A ...
Prior exposure to IL-36R inhibitors including spesolimab. Treatment with any investigational device or investigational drug of chemical or biologic nature ...
Anthracyclines cause inhibition of DNA polymerases and DNA fragmentation ... kinase inhibitors (the "dual hit" theory). Kinase Inhibitors. Protein ...
Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, may fight breast cancer by lowering the amount of estrogen the body makes. Drugs used ...
Subject is using pramlintide (Symlin), DPP-4 inhibitor, liraglutide ... inhibitors) at time of Visit 1. Subject has a history of visual impairment ...
Concomitant anti-neoplastic anti-hormonal therapy (including tamoxifen, aromatase inhibitors etc.) is not allowed for patients participating in study treatment.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!